The supply stood at 45,901 units with 36 per cent of the launches in price range Rs 50L-1cr. in Q1 2024, the PropEquity data ...

ADMA Biologics' revenue growth has plateaued over the last three quarters, raising concerns about near-term momentum. See why ...

The digital asset landscape is no longer confined to speculative sentiment. With regulatory clarity advancing in major ...